Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2006 1
2007 1
2009 1
2012 1
2013 1
2014 3
2015 4
2016 4
2017 4
2018 4
2019 7
2020 5
2021 5
2022 7
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Clinical cancer research in vulnerable populations.
Tack L, Schofield P, Boterberg T, Parris CN, Debruyne PR. Tack L, et al. Among authors: debruyne pr. Front Oncol. 2023 Mar 2;13:1166714. doi: 10.3389/fonc.2023.1166714. eCollection 2023. Front Oncol. 2023. PMID: 36937380 Free PMC article. No abstract available.
PSMA expression on neovasculature of solid tumors.
Van de Wiele C, Sathekge M, de Spiegeleer B, De Jonghe PJ, Debruyne PR, Borms M, Beels L, Maes A. Van de Wiele C, et al. Among authors: debruyne pr. Histol Histopathol. 2020 Sep;35(9):919-927. doi: 10.14670/HH-18-215. Epub 2020 Apr 13. Histol Histopathol. 2020. PMID: 32282924 Review.
Pain Medication Adherence in Patients with Cancer: A Pragmatic Review.
Vanneste L, Lefebvre T, Tack L, Van Eygen K, Cool L, Schofield PA, Boterberg T, De Rijdt T, Verhaeghe A, Verhelle K, Debruyne PR. Vanneste L, et al. Among authors: debruyne pr. Pain Med. 2022 Apr 8;23(4):782-798. doi: 10.1093/pm/pnab010. Pain Med. 2022. PMID: 33502510 Review.
Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire.
van Leeuwen M, Kieffer JM, Young TE, Annunziata MA, Arndt V, Arraras JI, Autran D, Hani HB, Chakrabarti M, Chinot O, Cho J, da Costa Vieira RA, Darlington AS, Debruyne PR, Dirven L, Doege D, Eller Y, Eichler M, Fridriksdottir N, Gioulbasanis I, Hammerlid E, van Hemelrijck M, Hermann S, Husson O, Jefford M, Johansen C, Kjaer TK, Kontogianni M, Lagergren P, Lidington E, Lisy K, Morag O, Nordin A, Al Omari ASH, Pace A, De Padova S, Petranovia D, Pinto M, Ramage J, Rammant E, Reijneveld J, Serpentini S, Sodergren S, Vassiliou V, Leeuw IV, Vistad I, Young T, Aaronson NK, van de Poll-Franse LV; EORTC QLG. van Leeuwen M, et al. Among authors: debruyne pr. J Cancer Surviv. 2023 Aug;17(4):1111-1130. doi: 10.1007/s11764-021-01160-1. Epub 2022 Jan 27. J Cancer Surviv. 2023. PMID: 35088246 Clinical Trial.
Functional status in older patients with cancer and a frailty risk profile: A multicenter observational study.
Meert G, Kenis C, Milisen K, Debruyne PR, De Groof I, Focan C, Cornélis F, Verschaeve V, Bachmann C, Bron D, Den Bulck HV, Schrijvers D, Langenaeken C, Specenier P, Jerusalem G, Praet JP, Lobelle JP, Flamaing J, Wildiers H, Decoster L. Meert G, et al. Among authors: debruyne pr. J Geriatr Oncol. 2022 Nov;13(8):1162-1171. doi: 10.1016/j.jgo.2022.08.019. Epub 2022 Sep 7. J Geriatr Oncol. 2022. PMID: 36085275
48 results